Jian Cui Selected Research

kushen

1/2020	The effect of compound kushen injection on cancer cells: Integrated identification of candidate molecular mechanisms.
10/2019	An effective drug sensitizing agent increases gefitinib treatment by down regulating PI3K/Akt/mTOR pathway and up regulating autophagy in non-small cell lung cancer.
1/2019	Cell cycle, energy metabolism and DNA repair pathways in cancer cells are suppressed by Compound Kushen Injection.
1/2019	Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection With Transcriptome Analysis.
1/2019	Effect of Compound Kushen Injection, a Natural Compound Mixture, and Its Identified Chemical Components on Migration and Invasion of Colon, Brain, and Breast Cancer Cell Lines.
10/2016	Identification of candidate anti-cancer molecular mechanisms of Compound Kushen Injection using functional genomics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jian Cui Research Topics

Disease

53	Neoplasms (Cancer) 03/2022 - 04/2003
13	Neoplasm Metastasis (Metastasis) 03/2022 - 01/2012
11	Lung Neoplasms (Lung Cancer) 01/2020 - 04/2013
9	Inflammation (Inflammations) 07/2022 - 02/2009
9	Pain (Aches) 04/2022 - 01/2011
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2017
7	Neuralgia (Stump Neuralgia) 01/2022 - 04/2011
7	Carcinogenesis 04/2021 - 04/2013
7	Breast Neoplasms (Breast Cancer) 04/2020 - 01/2012
6	Hypoxia (Hypoxemia) 01/2019 - 09/2009
5	Adenocarcinoma of Lung 05/2022 - 08/2011
5	Wounds and Injuries (Trauma) 04/2022 - 01/2011
5	Atherosclerosis 01/2022 - 11/2010
5	Hyperalgesia 01/2022 - 01/2012
5	Rectal Neoplasms (Rectal Cancer) 12/2020 - 06/2015
4	Fibrosis (Cirrhosis) 01/2021 - 01/2019
4	Intervertebral Disc Displacement (Herniated Disc) 05/2017 - 03/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 07/2018
3	Hypertension (High Blood Pressure) 03/2022 - 02/2005
3	Infections 01/2022 - 01/2016
3	Ischemia 08/2021 - 09/2007
3	Colorectal Neoplasms (Colorectal Cancer) 04/2021 - 05/2020
3	Colonic Neoplasms (Colon Cancer) 11/2020 - 01/2011
3	Hepatitis B 01/2020 - 03/2015
3	Prostatic Neoplasms (Prostate Cancer) 12/2019 - 01/2015
3	Glioma (Gliomas) 10/2018 - 10/2006
3	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 03/2003
3	Flatulence 01/2017 - 02/2014
3	Obesity 01/2016 - 11/2010
3	Hepatopulmonary Syndrome 11/2015 - 01/2014
3	Vascular Remodeling 08/2015 - 10/2005
3	Carcinoma (Carcinomatosis) 01/2015 - 07/2011
3	Esophageal Neoplasms (Esophageal Cancer) 04/2014 - 03/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 07/2022 - 04/2018
2	Thrombosis (Thrombus) 06/2022 - 01/2021
2	Insulin Resistance 01/2022 - 02/2014
2	Major Depressive Disorder (Major Depressive Disorders) 12/2021 - 01/2012
2	Ulcerative Colitis 08/2021 - 11/2019
2	Heart Failure 04/2021 - 01/2015
2	Colitis 01/2021 - 06/2020
2	Hyperthermia 01/2021 - 10/2005
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021 - 01/2020
2	Hyperbilirubinemia 01/2021 - 09/2015

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 11/2020 - 04/2003
11	Messenger RNA (mRNA)IBA 01/2022 - 10/2006
10	CytokinesIBA 03/2022 - 02/2009
8	Pharmaceutical PreparationsIBA 01/2021 - 06/2013
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 05/2011
6	LipidsIBA 07/2022 - 11/2010
6	kushenIBA 01/2020 - 10/2016
5	Small Interfering RNA (siRNA)IBA 03/2022 - 08/2011
5	Therapeutic UsesIBA 08/2021 - 04/2018
5	MicroRNAs (MicroRNA)IBA 04/2021 - 01/2015
5	Biomarkers (Surrogate Marker)IBA 04/2020 - 09/2014
4	Particulate MatterIBA 03/2022 - 01/2019
4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2017
4	Circular RNAIBA 01/2020 - 01/2018
4	Interleukin-6 (Interleukin 6)IBA 01/2016 - 07/2012
3	Receptor for Advanced Glycation End ProductsIBA 07/2022 - 01/2018
3	Streptozocin (Streptozotocin)FDA Link 01/2022 - 06/2011
3	AntioxidantsIBA 01/2022 - 09/2009
3	C-Reactive ProteinIBA 01/2021 - 02/2014
3	Caspase 3 (Caspase-3)IBA 11/2020 - 04/2015
3	CollagenIBA 01/2020 - 02/2011
3	VaccinesIBA 01/2020 - 06/2015
3	AntigensIBA 08/2019 - 05/2013
3	ChemokinesIBA 01/2019 - 11/2010
3	Polysaccharides (Glycans)IBA 01/2018 - 04/2003
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2018 - 01/2017
3	Adenosine Triphosphate (ATP)IBA 09/2017 - 04/2011
3	Protein Isoforms (Isoforms)IBA 12/2009 - 03/2005
2	Apolipoproteins E (ApoE)IBA 07/2022 - 06/2013
2	Histones (Histone)IBA 06/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2020
2	Dexmedetomidine FDA Link 01/2022 - 09/2015
2	Long Noncoding RNAIBA 01/2022 - 10/2016
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 02/2014
2	Vasodilator Agents (Vasodilators)IBA 10/2021 - 10/2005
2	AlbuminsIBA 01/2021 - 01/2020
2	Dextran SulfateIBA 01/2021 - 11/2019
2	andrographolide sulfonateIBA 12/2020 - 06/2020
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2020 - 08/2003
2	Transcription Factors (Transcription Factor)IBA 05/2020 - 08/2011
2	Progesterone Receptors (Progesterone Receptor)IBA 04/2020 - 01/2018
2	Phenobarbital (Luminal)FDA Link 04/2020 - 01/2018
2	Estrogen ReceptorsIBA 04/2020 - 01/2018
2	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2020 - 04/2003
2	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2020 - 01/2016
2	HydrogelsIBA 01/2020 - 01/2019

Therapy/Procedure

18	Therapeutics 04/2022 - 06/2015
6	Length of Stay 01/2017 - 01/2011
5	Neoadjuvant Therapy 12/2020 - 06/2015
5	Drug Therapy (Chemotherapy) 05/2017 - 04/2003
4	Ligation 09/2017 - 01/2012
3	Anesthesia 07/2021 - 06/2015
3	Operative Time 01/2018 - 01/2011
2	Punctures 04/2022 - 05/2017
2	Aftercare (After-Treatment) 04/2021 - 12/2019
2	Radiotherapy 04/2021 - 04/2003
2	Intraperitoneal Injections 12/2020 - 09/2015